Track Novozymes A/S's current cash ($460M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), NVZMF shows a current cash of $460M. That compares with $280M in the prior-year period — up 61.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NVZMF's current cash is now $460M (was $280M) — a 61.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Novozymes A/S is outperforming or lagging.
Tracking NVZMF's current cash over time shows whether Novozymes A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $460M That compares with $280M in the prior-year period — up 61.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Novozymes A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $460M) with ownership activity and broader fundamentals.